Copyright Reports & Markets. All rights reserved.

Global Herpes Simplex Virus Infection Treatment Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Herpes Simplex Virus Infection Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Herpes Simplex Virus-1 (HSV-1) Infection
    • 1.2.3 Herpes Simplex Virus-2 (HSV-2) Infection
    • 1.2.4 HSV1 & HSV2 Co-infection
  • 1.3 Market by Application
    • 1.3.1 Global Herpes Simplex Virus Infection Treatment Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Hospital Pharmacies
    • 1.3.3 Retail Pharmacies
    • 1.3.4 Online Pharmacies
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Herpes Simplex Virus Infection Treatment Market Perspective (2016-2027)
  • 2.2 Herpes Simplex Virus Infection Treatment Growth Trends by Regions
    • 2.2.1 Herpes Simplex Virus Infection Treatment Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Herpes Simplex Virus Infection Treatment Historic Market Share by Regions (2016-2021)
    • 2.2.3 Herpes Simplex Virus Infection Treatment Forecasted Market Size by Regions (2022-2027)
  • 2.3 Herpes Simplex Virus Infection Treatment Industry Dynamic
    • 2.3.1 Herpes Simplex Virus Infection Treatment Market Trends
    • 2.3.2 Herpes Simplex Virus Infection Treatment Market Drivers
    • 2.3.3 Herpes Simplex Virus Infection Treatment Market Challenges
    • 2.3.4 Herpes Simplex Virus Infection Treatment Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Herpes Simplex Virus Infection Treatment Players by Revenue
    • 3.1.1 Global Top Herpes Simplex Virus Infection Treatment Players by Revenue (2016-2021)
    • 3.1.2 Global Herpes Simplex Virus Infection Treatment Revenue Market Share by Players (2016-2021)
  • 3.2 Global Herpes Simplex Virus Infection Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Herpes Simplex Virus Infection Treatment Revenue
  • 3.4 Global Herpes Simplex Virus Infection Treatment Market Concentration Ratio
    • 3.4.1 Global Herpes Simplex Virus Infection Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Herpes Simplex Virus Infection Treatment Revenue in 2020
  • 3.5 Herpes Simplex Virus Infection Treatment Key Players Head office and Area Served
  • 3.6 Key Players Herpes Simplex Virus Infection Treatment Product Solution and Service
  • 3.7 Date of Enter into Herpes Simplex Virus Infection Treatment Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Herpes Simplex Virus Infection Treatment Breakdown Data by Type

  • 4.1 Global Herpes Simplex Virus Infection Treatment Historic Market Size by Type (2016-2021)
  • 4.2 Global Herpes Simplex Virus Infection Treatment Forecasted Market Size by Type (2022-2027)

5 Herpes Simplex Virus Infection Treatment Breakdown Data by Application

  • 5.1 Global Herpes Simplex Virus Infection Treatment Historic Market Size by Application (2016-2021)
  • 5.2 Global Herpes Simplex Virus Infection Treatment Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Herpes Simplex Virus Infection Treatment Market Size (2016-2027)
  • 6.2 North America Herpes Simplex Virus Infection Treatment Market Size by Type
    • 6.2.1 North America Herpes Simplex Virus Infection Treatment Market Size by Type (2016-2021)
    • 6.2.2 North America Herpes Simplex Virus Infection Treatment Market Size by Type (2022-2027)
    • 6.2.3 North America Herpes Simplex Virus Infection Treatment Market Size by Type (2016-2027)
  • 6.3 North America Herpes Simplex Virus Infection Treatment Market Size by Application
    • 6.3.1 North America Herpes Simplex Virus Infection Treatment Market Size by Application (2016-2021)
    • 6.3.2 North America Herpes Simplex Virus Infection Treatment Market Size by Application (2022-2027)
    • 6.3.3 North America Herpes Simplex Virus Infection Treatment Market Size by Application (2016-2027)
  • 6.4 North America Herpes Simplex Virus Infection Treatment Market Size by Country
    • 6.4.1 North America Herpes Simplex Virus Infection Treatment Market Size by Country (2016-2021)
    • 6.4.2 North America Herpes Simplex Virus Infection Treatment Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.3 Canada

7 Europe

  • 7.1 Europe Herpes Simplex Virus Infection Treatment Market Size (2016-2027)
  • 7.2 Europe Herpes Simplex Virus Infection Treatment Market Size by Type
    • 7.2.1 Europe Herpes Simplex Virus Infection Treatment Market Size by Type (2016-2021)
    • 7.2.2 Europe Herpes Simplex Virus Infection Treatment Market Size by Type (2022-2027)
    • 7.2.3 Europe Herpes Simplex Virus Infection Treatment Market Size by Type (2016-2027)
  • 7.3 Europe Herpes Simplex Virus Infection Treatment Market Size by Application
    • 7.3.1 Europe Herpes Simplex Virus Infection Treatment Market Size by Application (2016-2021)
    • 7.3.2 Europe Herpes Simplex Virus Infection Treatment Market Size by Application (2022-2027)
    • 7.3.3 Europe Herpes Simplex Virus Infection Treatment Market Size by Application (2016-2027)
  • 7.4 Europe Herpes Simplex Virus Infection Treatment Market Size by Country
    • 7.4.1 Europe Herpes Simplex Virus Infection Treatment Market Size by Country (2016-2021)
    • 7.4.2 Europe Herpes Simplex Virus Infection Treatment Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size (2016-2027)
  • 8.2 Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Type
    • 8.2.1 Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Application
    • 8.3.1 Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Region
    • 8.4.1 Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Herpes Simplex Virus Infection Treatment Market Size (2016-2027)
  • 9.2 Latin America Herpes Simplex Virus Infection Treatment Market Size by Type
    • 9.2.1 Latin America Herpes Simplex Virus Infection Treatment Market Size by Type (2016-2021)
    • 9.2.2 Latin America Herpes Simplex Virus Infection Treatment Market Size by Type (2022-2027)
    • 9.2.3 Latin America Herpes Simplex Virus Infection Treatment Market Size by Type (2016-2027)
  • 9.3 Latin America Herpes Simplex Virus Infection Treatment Market Size by Application
    • 9.3.1 Latin America Herpes Simplex Virus Infection Treatment Market Size by Application (2016-2021)
    • 9.3.2 Latin America Herpes Simplex Virus Infection Treatment Market Size by Application (2022-2027)
    • 9.3.3 Latin America Herpes Simplex Virus Infection Treatment Market Size by Application (2016-2027)
  • 9.4 Latin America Herpes Simplex Virus Infection Treatment Market Size by Country
    • 9.4.1 Latin America Herpes Simplex Virus Infection Treatment Market Size by Country (2016-2021)
    • 9.4.2 Latin America Herpes Simplex Virus Infection Treatment Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size (2016-2027)
  • 10.2 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Type
    • 10.2.1 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Application
    • 10.3.1 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Country
    • 10.4.1 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 F. Hoffmann-La Roche Ltd
    • 11.1.1 F. Hoffmann-La Roche Ltd Company Details
    • 11.1.2 F. Hoffmann-La Roche Ltd Business Overview
    • 11.1.3 F. Hoffmann-La Roche Ltd Herpes Simplex Virus Infection Treatment Introduction
    • 11.1.4 F. Hoffmann-La Roche Ltd Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
    • 11.1.5 F. Hoffmann-La Roche Ltd Recent Development
  • 11.2 Sanofi
    • 11.2.1 Sanofi Company Details
    • 11.2.2 Sanofi Business Overview
    • 11.2.3 Sanofi Herpes Simplex Virus Infection Treatment Introduction
    • 11.2.4 Sanofi Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
    • 11.2.5 Sanofi Recent Development
  • 11.3 Teva Pharmaceuticals Inc
    • 11.3.1 Teva Pharmaceuticals Inc Company Details
    • 11.3.2 Teva Pharmaceuticals Inc Business Overview
    • 11.3.3 Teva Pharmaceuticals Inc Herpes Simplex Virus Infection Treatment Introduction
    • 11.3.4 Teva Pharmaceuticals Inc Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
    • 11.3.5 Teva Pharmaceuticals Inc Recent Development
  • 11.4 Merck & Co., Inc
    • 11.4.1 Merck & Co., Inc Company Details
    • 11.4.2 Merck & Co., Inc Business Overview
    • 11.4.3 Merck & Co., Inc Herpes Simplex Virus Infection Treatment Introduction
    • 11.4.4 Merck & Co., Inc Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
    • 11.4.5 Merck & Co., Inc Recent Development
  • 11.5 Apotex Inc
    • 11.5.1 Apotex Inc Company Details
    • 11.5.2 Apotex Inc Business Overview
    • 11.5.3 Apotex Inc Herpes Simplex Virus Infection Treatment Introduction
    • 11.5.4 Apotex Inc Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
    • 11.5.5 Apotex Inc Recent Development
  • 11.6 Viatris
    • 11.6.1 Viatris Company Details
    • 11.6.2 Viatris Business Overview
    • 11.6.3 Viatris Herpes Simplex Virus Infection Treatment Introduction
    • 11.6.4 Viatris Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
    • 11.6.5 Viatris Recent Development
  • 11.7 Epi Health LLC
    • 11.7.1 Epi Health LLC Company Details
    • 11.7.2 Epi Health LLC Business Overview
    • 11.7.3 Epi Health LLC Herpes Simplex Virus Infection Treatment Introduction
    • 11.7.4 Epi Health LLC Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
    • 11.7.5 Epi Health LLC Recent Development
  • 11.8 Zydus Pharmaceuticals
    • 11.8.1 Zydus Pharmaceuticals Company Details
    • 11.8.2 Zydus Pharmaceuticals Business Overview
    • 11.8.3 Zydus Pharmaceuticals Herpes Simplex Virus Infection Treatment Introduction
    • 11.8.4 Zydus Pharmaceuticals Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
    • 11.8.5 Zydus Pharmaceuticals Recent Development
  • 11.9 GlaxoSmithKline LLC
    • 11.9.1 GlaxoSmithKline LLC Company Details
    • 11.9.2 GlaxoSmithKline LLC Business Overview
    • 11.9.3 GlaxoSmithKline LLC Herpes Simplex Virus Infection Treatment Introduction
    • 11.9.4 GlaxoSmithKline LLC Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
    • 11.9.5 GlaxoSmithKline LLC Recent Development
  • 11.10 Carlsbad Tech
    • 11.10.1 Carlsbad Tech Company Details
    • 11.10.2 Carlsbad Tech Business Overview
    • 11.10.3 Carlsbad Tech Herpes Simplex Virus Infection Treatment Introduction
    • 11.10.4 Carlsbad Tech Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
    • 11.10.5 Carlsbad Tech Recent Development
  • 11.11 Avet Pharmaceuticals Inc
    • 11.11.1 Avet Pharmaceuticals Inc Company Details
    • 11.11.2 Avet Pharmaceuticals Inc Business Overview
    • 11.11.3 Avet Pharmaceuticals Inc Herpes Simplex Virus Infection Treatment Introduction
    • 11.11.4 Avet Pharmaceuticals Inc Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
    • 11.11.5 Avet Pharmaceuticals Inc Recent Development
  • 11.12 Glenmark Pharmaceuticals
    • 11.12.1 Glenmark Pharmaceuticals Company Details
    • 11.12.2 Glenmark Pharmaceuticals Business Overview
    • 11.12.3 Glenmark Pharmaceuticals Herpes Simplex Virus Infection Treatment Introduction
    • 11.12.4 Glenmark Pharmaceuticals Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
    • 11.12.5 Glenmark Pharmaceuticals Recent Development
  • 11.13 Fresenius Kabi
    • 11.13.1 Fresenius Kabi Company Details
    • 11.13.2 Fresenius Kabi Business Overview
    • 11.13.3 Fresenius Kabi Herpes Simplex Virus Infection Treatment Introduction
    • 11.13.4 Fresenius Kabi Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
    • 11.13.5 Fresenius Kabi Recent Development
  • 11.14 Agenus, Inc
    • 11.14.1 Agenus, Inc Company Details
    • 11.14.2 Agenus, Inc Business Overview
    • 11.14.3 Agenus, Inc Herpes Simplex Virus Infection Treatment Introduction
    • 11.14.4 Agenus, Inc Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
    • 11.14.5 Agenus, Inc Recent Development
  • 11.15 Maruho Co. Ltd
    • 11.15.1 Maruho Co. Ltd Company Details
    • 11.15.2 Maruho Co. Ltd Business Overview
    • 11.15.3 Maruho Co. Ltd Herpes Simplex Virus Infection Treatment Introduction
    • 11.15.4 Maruho Co. Ltd Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
    • 11.15.5 Maruho Co. Ltd Recent Development
  • 11.16 AiCuris Anti-infective Cures GmbH
    • 11.16.1 AiCuris Anti-infective Cures GmbH Company Details
    • 11.16.2 AiCuris Anti-infective Cures GmbH Business Overview
    • 11.16.3 AiCuris Anti-infective Cures GmbH Herpes Simplex Virus Infection Treatment Introduction
    • 11.16.4 AiCuris Anti-infective Cures GmbH Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
    • 11.16.5 AiCuris Anti-infective Cures GmbH Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Herpes Simplex Virus Infection Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Herpes Simplex Virus Infection Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    By Type
    Herpes Simplex Virus-1 (HSV-1) Infection
    Herpes Simplex Virus-2 (HSV-2) Infection
    HSV1 & HSV2 Co-infection
    By Route of Administration
    Oral
    Parenteral
    By Drug Molecule
    Small Molecule
    Vaccine

    Segment by Application
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    F. Hoffmann-La Roche Ltd
    Sanofi
    Teva Pharmaceuticals Inc
    Merck & Co., Inc
    Apotex Inc
    Viatris
    Epi Health LLC
    Zydus Pharmaceuticals
    GlaxoSmithKline LLC
    Carlsbad Tech
    Avet Pharmaceuticals Inc
    Glenmark Pharmaceuticals
    Fresenius Kabi
    Agenus, Inc
    Maruho Co. Ltd

    Buy now